1 Min Read
NEW DELHI, Aug 26 (Reuters) - Bayer India executive said on Friday that nobody would invest in research with compulsory licensing. (Reporting by Krishna Das and Mayank Bhardwaj)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.